Login here to update your profile  
My Profile

Kendra Vehik,  MPH, PhD


Primary Department: COLLEGE OF MEDICINE PEDIATRICS

Assistant Professor
COPH EPIDEMIOLOGY & BIOSTATISTICS

Associate Professor
COLLEGE OF MEDICINE PEDIATRICS

profile Image
Contacts
Email: kvehik@health.usf.edu
Office: MDC, 113
Mailing address 3650 Spectrum Blvd. STE 100
Tampa, FL 33612
 
Education
  • PhD, Analytic Health Sciences, University Of Colorado , United States - 2007.
  • Ph.D., Epidemiology, University of Colorado ,USA - 2007.
  • M.P.H., Epidemiology and Biostatistics, George Washington University ,USA - 1996.
  • B.S., Biology, University of Arizona ,USA - 1993.
  •  
     
    Research Summary

    Dr. Kendra Vehik is an Assistant Professor at the University of South Florida. Her research interests are focused on type 1 diabetes including prevention, clinical/translational and quality of life research. Much of her published work has been focused on identifying probable risk factors associated with type 1 diabetes in order to develop more directed hypotheses to prevent the onset of autoimmunity and clinical disease. She has expertise in epidemiologic and biostatistical methodologies associated with case/control, longitudinal and clinical trial designs. Dr. Vehik has firsthand knowledge and experience working with many type 1 clinical projects coordinated by the Pediatric Epidemiology Center, including The Environmental Determinants of Diabetes in the Young (TEDDY), TrialNet Network and the Diabetes Prevention Trial – Type 1 (DPT-1) studies. Her main diabetes expertise lies in identifying stable and informative risk factors and validating the identified risk factors as triggers and/or accelerators of autoimmunity and clinical disease. She has authored many high impact peer-reviewed publications that have focused on determining risk factors associated with type 1 diabetes focused on in utero and early life environmental exposures (body size and growth patterns, nutrition, infections), genetic susceptibility, clinical outcomes in delaying onset and population-based temporal trends in risk factors and type 1 diabetes. Her long time interests are in identifying early life risk factors, exploring how changes in these risk factors over time and potential gene-environment interactions contribute to the risk of autoantibody seroconversion and surrogate biomarkers for prediction, diagnosis and risk of type 1 diabetes, and delaying or stopping the onset of diabetes.

     


    Selected Publications
  • Vehik, K.Cuthbertson, D.Boulware, D.Beam, CA.Rodriguez, H.Legault, L.Hyytinen, M.Rewers, MJ.Schatz, DA.Krischer, JP. Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth. Diabetes care. 35(9): 1821-5, 2012.
  • Vehik, K.Dabelea, D. Why are C-section deliveries linked to childhood type 1 diabetes? Diabetes. 61(1): 36-7, 2012.
  • Vehik, K.Beam, CA.Mahon, JL.Schatz, DA.Haller, MJ.Sosenko, JM.Skyler, JS.Krischer, JP. Development of autoantibodies in the TrialNet Natural History Study. Diabetes care. 34(9): 1897-901, 2011.
  • Vehik, K.Cuthbertson, D.Ruhlig, H.Schatz, DA.Peakman, M.Krischer, JP. Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial. Diabetes care. 34(7): 1585-90, 2011.
  • Vehik, K.Haller, MJ.Beam, CA.Schatz, DA.Wherrett, DK.Sosenko, JM.Krischer, JP. Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood. Diabetes care. 34(2): 358-62, 2011.
  • Vehik, K.Dabelea, D. The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes/metabolism research and reviews. 27(1): 3-13, 2011.
  • Richesson, R.Vehik, K. Patient registries: utility, validity and inference. Advances in experimental medicine and biology. 686(): 87-104, 2010.
  • Vehik, K.Hamman, RF.Lezotte, D.Norris, JM.Klingensmith, GJ.Dabelea, D. Childhood growth and age at diagnosis with Type 1 diabetes in Colorado young people. Diabetic medicine : a journal of the British Diabetic Association. 26(10): 961-7, 2009.
  • Vehik, K.Hamman, RF.Lezotte, D.Norris, JM.Klingensmith, GJ.Rewers, M.Dabelea, D. Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes. Diabetes care. 31(7): 1392-6, 2008.
  • Vehik, K.Hamman, RF.Lezotte, D.Norris, JM.Klingensmith, G.Bloch, C.Rewers, M.Dabelea, D. Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth. Diabetes care. 30(3): 503-9, 2007.

  • Profile last modified on 09/30/2013